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Summary In HT29 cells 5-fluorouracil (5FU) cytotoxicity is enhanced by subsequent incubation of cells in
medium containing 1% N-methylformamide (NMF). This enhancement does not appear to be related to
differences in the repair of 5FU-induced DNA damage. It is proposed that the inhibition of DNA synthesis by
NMF (that is reversible and does not result in any detectable toxicity) becomes a lethal event in a cell in which
DNA synthesis has already been altered by 5FU exposure. The synergism is sequence dependent (i.e. it does
not occur when NMF is given before 5FU) and specific for some cell types as shown by the fact that no
synergism was found in L1210 mouse leukaemia cells. In nude mice transplanted s.c. with HT29 cells daily
5FU treatment (for 5 days) followed by daily NMF treatment (for 10 days) caused much greater inhibition of
tumour growth than either drug alone or the same combination given in the opposite order (NMF then 5FU).
These results, if confirmed on other human colon tumours, could be of clinical interest as a means of
increasing the therapeutic efficacy of 5FU in patients with colon cancer.
The polar solvent N-methylformamide (NMF) has recently
been reported to induce the expression of a better
differentiated or less malignant phenotype in both rodent and
human tumour cells (Langdon & Hickman, 1987). Cellular
alterations associated with NMF-mediated induction of
differentiation include changes in morphology, clonogenicity,
tumorigenicity and cell culture doubling time (Zupi et al.,
1988), which ultimately result in a lower tumour aggres-
siveness. NMF-treated cells revert to the original phenotype
upon removal of the inducer, but the maturational treatment
has been associated with increased tumour cell sensitivity to
certain cytotoxic agents, such as X-rays, cisplatinum and
bleomycin (Dexter et al., 1984; Harpur et al., 1986; Langdon
et al., 1985; Leith et al., 1985, 1986). It has been proposed
that the sequential use of cytotoxic and differentiating agents
might improve anti-cancer therapy by preventing or slowing
tumour cell proliferation and phenotypic diversification
(Lotan & Nicolson, 1988).
In the human colon cancer cell line HT29 we have already
studied the lethal effects of the combination of NMF and
5-fluorouracil (5FU) (Zupi et al., 1988). 5FU cytotoxicity
was potentiated by subsequent exposure of cells to a non-
toxic dose of NMF (1%), but when the two compounds were
given in the opposite sequence there was no synergism. The
enhanced cytotoxicity of the sequence 5FU to NMF could be
related to the NMF-treated cells being less able to recover
from the sublethal damage produced by the anti-metabolite.
In order to shed some light on the mechanism of this
potentiation we designed a study to assess the DNA damage
and alteration of macromolecule synthesis caused by 5FU
alone or SFU followed by NMF on HT29 cells.
Materials and methods
Cell cultures
The HT29 colon adenocarcinoma cell line was maintained as
monolayer culture in RPMI 1640 medium supplemented with
10% FCS, L-glutamine and antibiotics. Cells were harvested
using 0.02% EDTA-0.05% trypsin solution. L1210 murine
leukaemia cells were grown as a suspension culture in RPMI
1640 medium supplemented with 10% heat-inactivated FCS,
L-glutamine, 20 mM Hepes and 10 IOM P-mercaptoethanol.
Both cell lines were maintained at 37°C in a humidified 5%
C02: 95% air atmosphere. All products were purchased from
GIBCO.
Chemicals anddrugs
N-Methylformamide (NMF, Sigma M2769) was diluted in
normal growth medium. 5-Fluorouracil (5FU, Roche S.p.a.,
Milano) as supplied for clinical use, was diluted in saline and
then in culture medium to the desired final concentration.
'4C-thymidine (spec.act. 61 mCi mmol-'), methyl-3H-thy-
midine (spec.act. 70-85 Ci mmol '), 5-3H-uridine (spec.act.
25-30 Ci mmol-') and L-4,5-3H-leucine (spec.act. 45-70
Ci mmol-') were obtained from Amersham International plc,
England.
Flow cytometry
For cell cycle studies, cells were stained with 2 ml of a
solution composed of the double-stranded nucleic acid probe
propidium iodide (Calbiochem Boehring Co., St Louis,
USA), 50 lig ml-' in 0.1% sodium citrate. Fifteen IlI of
RNase (Calbiochem) 0.5 mg ml-' stock solution were added
to the cell suspension to disrupt the cytoplasm completely
and eliminate any disturbances due to double-stranded RNA.
After at least 30 min incubation at room temperature, sam-
ples were analysed using an Ortho 30L Cytofluorograph
(Ortho Instruments, Westwood, USA) and the percentages of
cells in cell cycle phases were calculated using the method of
Krishan and Frei (1976). Each cytofluorographic assay was
performed on 20-40 x 103 cells. Experiments were repeated
three times. The coefficient of variation (CV) of the GI peak
of HT29 cells was 4%.
Clonogenic assay
HT29 cells were exposed to graded doses of 5FU (5, 10,
15 igml-') for 12h at 37°C. In combination experiments,
cells were pre- or post-treated with 1% NMF for 72 h then
exposed to increasing doses of 5FU for 12 h. After exposure,
the drug-containing medium was removed, the cells were
washed with balanced salt solution, harvested as
monodispersed suspension and counted. Known aliquots of
cell suspension were seeded in 60-mm Petri dishes into NMF-
free medium so that colonies would appear after 14 days of
incubation. Colonies were stained with 2% methylene blue in
95% ethanol.
L1210 cells were exposed to graded doses of 5FU (0.1, 0.5,
1.0 jgml-') for 16h at 37°C. For the combined treatment,
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after 5FU exposure cells were incubated in growth medium
containing 1% NMF for 72 h. The clonogenic ability of
treated cells was evaluated by a soft-agar colony assay.
Leukaemic colonies were grown by plating the cells in 0.3%
agar on the top of a 0.5% agar underlayer. At the end of
drug treatment cells were centrifuged, washed in PBS and
counted with a haemocytometer. Appropriate dilutions were
made to plate 600 viable cells (as determined by erythrosin B
dye exclusion test) into 2cm2 wells of a 24-well plate (Fal-
con). After 8 days of incubation colonies (,>50 cells) were
fixed with methanol for 30 s, stained with Mayer's haematox-
ylin solution for 30 s and counted under a microscope at
10 x magnification.
For the cell lines in combination experiments the NMF-
treated cells were taken as control sample and the surviving
fraction was calculated by dividing the absolute survival of
the treated sample by the absolute survival of the control
sample at the same time. Each experimental point was deter-
mined in quadruplicate. Experiments were repeated twice.
Alkaline elution studies
To evaluate DNA single strand breaks (SSB) caused by 5FU
incorporation in DNA synthesised during drug treatment,
exponentially growing HT29 cells were simultaneously
exposed to 5FU (1, 5, 10 and 20 igml-') and 0.04 sCiml-'
'4C-thymidine for 16 h. Cells were then washed once in PBS
and incubated in NMF-containing and NMF-free medium
for 72 h. At different times during this period, alkaline elu-
tion experiments were performed according to the method
recently reviewed in detail by Kohn et al. (1981). Briefly,
about 106 cells were resuspended in cold PBS and layered on
polycarbonate filters, 0.8 gm pore size and 25 mm diameter
(Nucleopore Corp., Pleasanton, USA). Cells were then lysed
with a solution containing 2% sodium dodecyl sulphate
(SDS), 0.02 M Na2 EDTA, 0.1 M glycine, pH 10.0 (lysis solu-
tion), which was allowed to flow through the filters by
gravity. The outlet of the filter holders was then connected to
the pumping system. DNA was eluted from the filters by
pumping 0.02 M EDTA solution adjusted to pH 12.6 with
tetrapropyl ammonium hydroxide (RSA Corp., Elmsford,
USA), containing 0.1% SDS through the filters at 2 ml h-'.
The pH of the elution buffer was 12.6 instead of the usual
12.1 because at higher pH the alkali labile sites are trans-
formed in DNA SSB during the elution time (Kohn et al.,
1981). Three-hour fractions were collected, and fractions and
filters processed as described previously (Kohn et al., 1981).
DNA, RNA andprotein synthesis
HT29 cells were seeded with 1 x 104 cells cm-2 in 35-mm
wells of a 6-multiwell culture plate (Falcon) and incubated in
a humidified atmosphere for 3 days. After 16 h of exposure
to S tg ml-' 5FU cells were allowed to recover in either the
absence or the presence of 1% NMF. Control wells were
processed by changing the medium at the same time as
treated samples. DNA, RNA and protein synthesis were
determined by adding radiolabelled precursors at different
times after 5FU exposure. The final concentration of each
radiolabelled precursor was 1 glCi ml-'. At the end of
radioisotope incubation (1 h) cells were washed once in PBS,
harvested and the cell suspension (2 ml) was mixed with 2 ml
of cold 10% trichloroacetic acid (TCA) and incubated at 4°C
overnight. The precipitate was collected on a 25 mm
diameter glass microfibre filter (Whatmann, GF/C) and
washed three times with 2 ml cold 5% TCA then twice with
2 ml ethanol. Dried filters were transferred to scintillation
vials with 1Oml Pico Fluor TM 15 (Packard) and radio-
activity was determined by an LS5800 ,-counter (Beckman
Instruments, Irvine, USA). Each point is the average of four
replications.
In vivo experiments
Male CD-1 background nu/nu mice (Charles River Labor-
atories, Calco, Italy), 6-8 weeks old, were employed. They
were inoculated in the lateral subcutis site with 2 x 106 cul-
tured HT29 cells and serially transplanted at 4-week inter-
vals. The single cell suspension was obtained from tumours
by a standard enzymatic procedure with 0.25% trypsin. Each
experimental group consisted of 8-10 animals. Treatment
was started when the tumour reached a weight of
120-150 mg (12-15 days post-implantation), according to
the following schedules: (a) 5FU 19 mgkg' day-' for five
consecutive days followed by NMF 200 mg kg-' day-' x 10
days; (b) NMF 200 mg kg-' day-' for 10 consecutive days
followed by 5FU 19 mgkg-' day-'x 5 days; (c) 5FU
19 mg kg-' day-' x 5 consecutive days followed by 0.9%
NaCl x 10 days; (d) 0.9% NaCl x 5 consecutive days fol-
lowed by NMF 200mgkg-' day-' x 10 days. All treat-
ments were repeated for two cycles, at 4-day intervals. Mice
in control groups received 0.2ml of 0.9% NaCl solution.
5FU was used at the dose equal to the LDO, and NMF was
employed at <LD10 assessed in tumour free mice.
The antitumoral effect of the treatments was evaluated in
terms of tumour weight inhibition (TWI) and growth delay.
Survival data could not be evaluated because tumour-bearing
nude mice never die a natural death before their tumour
volume and general conditions make euthanasia ethically
necessary.
Results and discussion
Figure 1 illustrates the results of a representative experiment
in which HT29 cells were exposed to 5FU for 12 h or to 5FU
followed or preceded by 1% NMF for 72 h. NMF had no
cytotoxic effect. It is evident that 5FU activity was poten-
tiated only when NMF was given after 5FU. Similar findings
have already been reported by this laboratory (Zupi et al.,
1988) and were verified also when 5FU exposure was pro-
longed up to 24 h (data not shown).
A possible explanation for the effect of NMF seen only
after 5FU treatment is that this compound prevented the
repair of DNA damage that has been reported in cells treated
with 5FU (Lonn & Lonn, 1984, 1986; Major et al., 1982).
This possibility was also suggested by the observation that
NMF reduced the size of the shoulder in the survival curve
of HT29 cells. By analogy with survival curves of cells
treated with radiation the shoulder could in fact reflect the
cells' ability to repair DNA damage caused by the lower
doses.
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Figure 1 Dose-response survival curves of HT29 cells exposed
to: 0, 5FU alone for 12 h; 0, 5FU for 12 h followed by 1%
NMF for 72 h; *, 1% NMF for 72 h followed by 5FU for 12 h.
Per cent survival of cells after 72 h of exposure to NMF was
93 ± 5.6. After incubation with the first agent cells were washed
with balanced salt solution and then exposed to the second agent.
Where not shown, the standard error is included in symbols.5FU-NMF COMBINATION 379
Using alkaline elution methods we attempted to compare
the DNA damage (i.e. DNA breaks plus DNA alkali labile
sites) produced by 5FU in HT29 cells and to assess whether
the rate of repair of DNA lesions was influenced by post
drug-treatment incubation in NMF containing medium. 5FU
caused a small number of DNA SSB in HT29 cells (Table I).
DNA SSB were only partially repaired at lower concentra-
tions (1 and 5 gg ml-') and NMF did not appear to influence
the repair capacity.
Previous studies indicated that 5FU (Yoshioka et al., 1987)
or other thymidylate synthase inhibitors (Lorico et al., 1988)
cause DNA double strand breaks which could be important
for drug cytotoxicity and that cycloheximide was reducing
both the DNA damage and cytotoxicity caused by these
compounds. Therefore we investigated whether 5FU or 5FU
and NMF were causing DNA double strand breaks by using
neutral elution techniques, but the results were negative (data
not shown). The fact that NMF potentiates 5FU cytotoxicity
without any substantial increase in DNA damage does not
bear out the importance of 5FU incorporation into DNA as
a crucial part of 5FU activity, at least in HT29 cells.
Since 5FU cytotoxicity could be related to the drug-
induced impairment of macromolecule synthesis
(Heidelberger, 1965), we investigated whether NMF
influenced the alterations of DNA, RNA and protein syn-
thesis in HT29 cells treated with 5FU (Figure 2). NMF alone
caused a gradual decline in 3H-thymidine incorporation
which became evident between 8 and 24 h of exposure. By
48 h of NMF treatment incorporation of the labelled precur-
sor was only 18% of control. In contrast, at the end of 5FU
Table I DNA single-strand breaks (SSB) caused by 5FU or by 5FU
followed by NMF in HT29 cells
SFU (figml-')
1 S 10 20
End of treatment" 15-18b 30-38 29-42 40-56
24h recovery 5 26-33 40-47 30-33
without NMF
24h recovery 4-6 16-22 33-40 21
with 1% NMF
48h recovery 4 15-17 24-28 34-35
without NMF
48h recovery 5-6 15-18 40-41 32-49
with 1% NMF
72h recovery 5-6 14-18 37-53 56-72
without NMF
72h recovery 3-4 18-20 52-68 80-90
with 1% NMF
aExposure time 16 h. bRange of DNA SSB in rad equivalents.
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exposure and all through the recovery period 3H-thymidine
incorporation was considerably increased. Probably cells
avidly incorporated 3H-thymidine because of depletion of the
intracellular thymidine nucleotide pool caused by 5FU-
induced inhibition of thymidylate synthase.
Similarly increased incorporation of 3H-thymidine was
observed in HT29 cells recovering from 5FU exposure in
NMF-containing medium, but only up to 24 h of recovery.
By 48 h of recovery, 3H-thymidine incorporation into DNA
was about the same as control cells, probably on account of
strong inhibition of DNA synthesis by NMF. As previously
reported in murine TLX5 lymphoma cells (Bill et al., 1988),
in HT29 human colon carcinoma cells NMF alone causes an
arrest ofcells in G1 (Table II shows the results of a represen-
tative experiment). Probably this blockade does not enhance
the cytotoxicity of 5FU (given after NMF), this drug being
specific to the S phase. On the other hand, when 5FU is
given alone, cells are arrested in S phase and this effect
becomes more marked when 5FU treatment is followed by
NMF. The NMF-induced inhibition of DNA synthesis, nor-
mally reversed without any cytoxocity upon NMF removal,
could thus be lethal in a cell whose DNA synthesis capacity
has already been impaired by 5FU.
Synthesis of RNA and proteins was not markedly affected
by 5FU. NMF reduced RNA synthesis only at later times (48
and 72 h) and this was also seen in HT29 cells pretreated
with 5FU. This effect may be a consequence of the inhibition
of DNA synthesis that appeared to be more marked and
occurred earlier.
The cytotoxic activity of 5FU was not enhanced when
Table II Flow cytometric analysis of cell cycle phase distribution in
HT29 cells exposed to 5FU alone, NMF alone or to 5FU followed
by NMF
GI SE2 SM3 SL + G2M2
Control 58.0 10.3 10.3 21.4
5FU alone 26.4 34.5 23.9 15.2
NMF alone 81.9 2.2 2.3 13.6
5FU followed 13.9 42.1 26.4 17.6
by NMF
HT29 cells were exposed to 0 or 5 igml-' 5FU for 16 h then
washed and incubated for 72 h in normal growth medium or in
medium containing 1% NMF. The flow cytometric analysis was
performed 24 h after 5FU removal. Cell cycle distribution was
calculated according to the method of Krishan and Frei (1976). The
results of the other two independent experiments were very similar to
those reported in the table with maximum variation of 2%.
'SE = early S phase; SM = middle S phase; SL = late S phase.
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Figure 2 Evaluation of DNA, RNA and protein synthesis in HT29 cells exposed to 5FU alone (dark columns), to NMF alone
(white columns) or to the sequence 5FU to NMF (hatched columns). Cells were seeded and treated with 5jig ml-' 5FU for 16 h
and then allowed to recover in either the absence or the presence of I% NMF for 72 h, as described in Materials and methods. To
evaluate the effect caused by NMF on macromolecule synthesis, cells were exposed to this agent at the same time as cells which had
previously been treated with 5FU. DNA, RNA and protein synthesis were determined adding radiolabelled precursors (methyl-3H-
thymidine, 5-3H-uridine, L-4,5,3H-leucine, I h at 37C) at the end of 5FU exposure (time 0) and at different times during the
recovery period in NMF-free or NMF-containing medium. Bars indicate the standard error. *P <0.01, Dunnett's test.380 N. LAUDONIO et al.
L1210 cells were exposed to NMF (Figure 3) for 72 h after
5FU treatment, suggesting that the synergism is specific for
some cell types.
Preliminary results of current investigations in nude mice
transplanted with HT29 cells (Table III) indicate that NMF
treatment in vivo can increase the anti-neoplastic activity of
5FU without raising its bone marrow and general toxicity,
thus confirming the data obtained in vitro. In fact, only the
5FU to NMF schedule consistently reduced tumour weight
(50% TWI) as compared to the reduction produced by the
opposite schedule, NMF to 5FU (12% TWI). This finding
gains in importance considering that 5FU alone was
ineffective against HT29 xenografts. NMF alone had a very
slight antitumoral effect (14% TWI). Concerning the NMF's
known hepatotoxicity, it is worth noting that in our experi-
mental conditions the different treatment schedules produced
very little toxicity. Body weight loss was < 10% of the initial
weight; haematological analysis and liver histology showed
acceptable and completely reversible NMF toxicity.
These results, if confirmed on other human colon tumours,
could be of potential clinical interest as a means of increasing
the therapeutic efficacy of 5FU in patients with colon cancer.
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Figure 3 Dose-response survival curves of L1210 murine
leukaemia cells exposed to: 0, 5FU for 16 h; *, 5FU for 16 h
followed by 1% NMF for 72 h. Per cent survival of cells after
72 h of exposure to NMF was 115 ± 3.7. After incubation with
the first agent cells were washed with PBS and then exposed to
the second agent. Where not shown the standard error is included
in symbols.
Table III Antitumoral effect of different treatment schedules on HT29 human colon cancer
xenografts
Tumour growthc
Tumour weightb delay (days,
Schedulesa inhibition (% ± s.e.) median (range)
5FU l9mgkg' day-' x 5 days followed by 50d±20 10.5 (5-18)
NMF 200mgkg' day-' x 10 days
NMF 200mgkg-' day-' x 10 days followed by 12± 5 2.5 (1-4)
5FU 19 mg kg-' day-' x 5 days
5FU 19mg kg-' day-' x 5 days followed by - 0.5 (0-1.5)
0.9% NaCl x 10 days
0.9% NaCI x 5 days followed by NMF 14 5.5 1.0 (0-2)
200 mg kg-' day-' x 10 days
dAll treatments were repeated for two cycles, at 4-day intervals;bTumour weights at the end of the
second cycle of treatment; cTime to reach 2 x 103 mg; dStatistically different (P <0.05) from values
of controls or of other groups as assessed by Dunnett test; 'Statistically different (P <0.01) from
values of controls or of other groups as assessed by Mann-Whitney test.
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